Charles D. Smith
17Patents
5h-index
15Co-inventors
63Inventor score
Filing activity: Jul 1, 1993 → Mar 7, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6248752A | Azabicyclooctane compositions and methods for enhancing chemotherapy | Human Necessities | 18 | Expired |
| US7338961B2 | Sphingosine kinase inhibitors | Chemistry; Metallurgy | 18 | Active |
| US8557800B2 | Sphingosine kinase inhibitors | Chemistry; Metallurgy | 10 | Active |
| US8063248B2 | Sphingosine kinase inhibitors | Chemistry; Metallurgy | 10 | Active |
| US8324237B2 | Methods for the treatment and prevention of inflammatory diseases | Human Necessities | 6 | Active |
| US5952298A | Cryptophycins | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7585865B2 | Protein kinase C zeta inhibition to treat vascular permeability | Human Necessities | 4 | Active |
| US6693112B2 | Compounds for enhancing chemotherapy | Chemistry; Metallurgy | 2 | Expired |
| US6537993B2 | Compounds for enhancing chemotherapy | Chemistry; Metallurgy | 2 | Expired |
| US8685936B2 | Sphingosine kinase inhibitor prodrugs | Chemistry; Metallurgy | 1 | Active |
| US5439933A | Scytophycin compounds, compositions and methods for their production and use | Chemistry; Metallurgy | 1 | Expired |
| USRE49811E1 | Sphingosine kinase inhibitors | General | 0 | Active |
| US5869650A | Dendroamide compounds and their use in chemosensitizing multidrug resistant cells | Chemistry; Metallurgy | 0 | Expired |
| US7220764B2 | Sphingosine kinase inhibitors | Human Necessities | 0 | Expired |
| US6815442B2 | Quinoxalinones for enhancing chemotherapy | Chemistry; Metallurgy | 0 | Expired |
| US8211893B2 | Protein kinase C zeta inhibition to treat diabetic retinopathy | Human Necessities | 0 | Active |
| US5955423A | Cryptophycins | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.